179 related articles for article (PubMed ID: 22272733)
1. Nebulized corticosteroids in asthma and COPD. An Italian appraisal.
Melani AS
Respir Care; 2012 Jul; 57(7):1161-74. PubMed ID: 22272733
[TBL] [Abstract][Full Text] [Related]
2. Compressor/nebulizers differences in the nebulization of corticosteroids. The CODE study (Corticosteroids and Devices Efficiency).
Terzano C; Petroianni A; Parola D; Ricci A
Eur Rev Med Pharmacol Sci; 2007; 11(4):225-37. PubMed ID: 17876957
[TBL] [Abstract][Full Text] [Related]
3. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.
Kantar A; Mroueh S; Fiocchi A
Allergy Asthma Proc; 2007; 28(6):671-87. PubMed ID: 17883883
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
Nicolini G; Cremonesi G; Melani AS
Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
[TBL] [Abstract][Full Text] [Related]
5. Nebulization of corticosteroids to asthmatic children: large variation in dose inhaled.
O'Callaghan C; White JA; Kantar A
Respirology; 2014 Feb; 19(2):276-279. PubMed ID: 24267983
[TBL] [Abstract][Full Text] [Related]
6. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
[TBL] [Abstract][Full Text] [Related]
7. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
Terzano C; Ricci A; Burinschi V; Nekam K; Lahovsky J
Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma.
Brocklebank D; Wright J; Cates C
BMJ; 2001 Oct; 323(7318):896-900. PubMed ID: 11668133
[TBL] [Abstract][Full Text] [Related]
10. Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy.
Lavorini F; Pedersen S; Usmani OS;
Chest; 2017 Jun; 151(6):1345-1355. PubMed ID: 27522955
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids administered by nebulization to children with bronchial asthma.
Terzano C; Barkai L; Cremonesi G
Adv Ther; 2001; 18(6):253-60. PubMed ID: 11841195
[TBL] [Abstract][Full Text] [Related]
12. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.
Decimo F; Maiello N; Miraglia Del Giudice M; Amelio R; Capristo C; Capristo AF
Int J Immunopathol Pharmacol; 2009; 22(2):363-70. PubMed ID: 19505390
[TBL] [Abstract][Full Text] [Related]
13. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
Kamada AK; Szefler SJ; Martin RJ; Boushey HA; Chinchilli VM; Drazen JM; Fish JE; Israel E; Lazarus SC; Lemanske RF
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1739-48. PubMed ID: 8665030
[No Abstract] [Full Text] [Related]
14. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
15. Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates.
Terzano C; Mannino F
J Aerosol Med; 1999; 12(4):249-54. PubMed ID: 10724639
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up.
Stempel DA; McLaughlin T; Griffis DL; Stanford RH
Respir Med; 2001 Dec; 95(12):992-8. PubMed ID: 11778798
[TBL] [Abstract][Full Text] [Related]
17. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
Thorsson L; Geller D
Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
[TBL] [Abstract][Full Text] [Related]
18. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
19. Aerosol characterization of nebulized intranasal glucocorticoid formulations.
Berlinski A; Waldrep JC
J Aerosol Med; 2001; 14(2):237-44. PubMed ID: 11681655
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults.
Brus R
Arch Intern Med; 1999 Sep; 159(16):1903-8. PubMed ID: 10493320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
